Related Articles
The risk factors of portal vein thrombosis in patients with liver cirrhosis
GPVI‑Fc‑PEG improves cerebral infarct volume and cerebral thrombosis in mouse model with cerebral thrombosis
Management of portal vein thrombosis in cirrhotic patients enlisted for liver transplantation: From diagnosis to treatment (Review)
Portal vein thrombosis: A concise review (Review)
Rivaroxaban attenuates thrombosis by targeting the NF-κB signaling pathway in a rat model of deep venous thrombus Retraction in /10.3892/ijmm.2018.3565